Franklin Biotechnology Discovery Fund Class C (FBTDX)
NASDAQ · Mutual Fund
· Delayed Price · Currency is USD
103.38
-0.16 (-0.15%)
Jun 20, 2025, 4:00 PM EDT
FBTDX Holdings List
As of May 31, 2025
No. | Symbol | Name | % Weight |
---|---|---|---|
1 | GILD | Gilead Sciences, Inc. | 8.17% |
2 | AMGN | Amgen Inc. | 7.64% |
3 | VRTX | Vertex Pharmaceuticals Incorporated | 7.25% |
4 | ASND | Ascendis Pharma A/S | 4.89% |
5 | REGN | Regeneron Pharmaceuticals, Inc. | 4.34% |
6 | ARGX | argenx SE | 3.80% |
7 | JAZZ | Jazz Pharmaceuticals plc | 3.79% |
8 | MRUS | Merus N.V. | 3.52% |
9 | PTCT | PTC Therapeutics, Inc. | 3.16% |
10 | NBIX | Neurocrine Biosciences, Inc. | 2.91% |
11 | BNTC | Benitec Biopharma Inc. | 2.77% |
12 | ALNY | Alnylam Pharmaceuticals, Inc. | 2.74% |
13 | INSM | Insmed Incorporated | 2.34% |
14 | AZN | AstraZeneca PLC | 2.21% |
15 | GH | Guardant Health, Inc. | 1.94% |
16 | ARQT | Arcutis Biotherapeutics, Inc. | 1.86% |
17 | INFXX | Institutional Fiduciary Trust - Money Market Portfolio | 1.84% |
18 | LLY | Eli Lilly and Company | 1.53% |
19 | MLYS | Mineralys Therapeutics, Inc. | 1.49% |
20 | MIRM | Mirum Pharmaceuticals, Inc. | 1.41% |
21 | SPRY | ARS Pharmaceuticals, Inc. | 1.40% |
22 | CNTA | Centessa Pharmaceuticals plc | 1.36% |
23 | QURE | uniQure N.V. | 1.22% |
24 | EYPT | EyePoint Pharmaceuticals, Inc. | 1.11% |
25 | CRNX | Crinetics Pharmaceuticals, Inc. | 1.03% |
26 | PCVX | Vaxcyte, Inc. | 1.01% |
27 | BBIO | BridgeBio Pharma, Inc. | 0.88% |
28 | CGON | CG Oncology, Inc. | 0.85% |
29 | APGE | Apogee Therapeutics, Inc. | 0.84% |
30 | SNDX | Syndax Pharmaceuticals, Inc. | 0.84% |
31 | DAWN | Day One Biopharmaceuticals, Inc. | 0.80% |
32 | CTMX | CytomX Therapeutics, Inc. | 0.80% |
33 | AVTR | Avantor, Inc. | 0.73% |
34 | CPH: ZEAL | Zealand Pharma A/S | 0.72% |
35 | AURA | Aura Biosciences, Inc. | 0.71% |
36 | n/a | Benitec Biopharma ([Wts/Rts]) | 0.71% |
37 | JANX | Janux Therapeutics, Inc. | 0.66% |
38 | PRAX | Praxis Precision Medicines, Inc. | 0.65% |
39 | GPCR | Structure Therapeutics Inc. | 0.62% |
40 | NUVL | Nuvalent, Inc. | 0.62% |
41 | CGEM | Cullinan Therapeutics, Inc. | 0.62% |
42 | SYRE | Spyre Therapeutics, Inc. | 0.62% |
43 | OLMA | Olema Pharmaceuticals, Inc. | 0.60% |
44 | TMO | Thermo Fisher Scientific Inc. | 0.51% |
45 | DYN | Dyne Therapeutics, Inc. | 0.51% |
46 | RARE | Ultragenyx Pharmaceutical Inc. | 0.50% |
47 | OCUL | Ocular Therapeutix, Inc. | 0.49% |
48 | ORKA | Oruka Therapeutics, Inc. | 0.48% |
49 | ACHV | Achieve Life Sciences, Inc. | 0.47% |
50 | SRPT | Sarepta Therapeutics, Inc. | 0.46% |
As of May 31, 2025